Screening for subclinical coronary and myocardial disease in subjects with diabetes and metabolic syndrome

被引：0
|
作者：
Wong, C. [1 ]
Leano, R. [1 ]
Haluska, B. [1 ]
Marwick, T. H. [1 ]
机构：
[1] Univ Queensland, Sch Med, Brisbane, Qld, Australia
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：527 / 527
页数：1
相关论文
共 50 条
  • [11] The metabolic syndrome, angiographically determined stable coronary artery disease, and subclinical inflammation
    Woess, M.
    Saely, C.
    Beer, S.
    Rein, P.
    Vonbank, A.
    Boelinel, C.
    Jankovic, V.
    Drexel, H.
    DIABETOLOGIA, 2008, 51 : S544 - S544
  • [12] The metabolic syndrome, angiographically determined stable coronary artery disease, and subclinical inflammation
    Rein, P.
    Beer, S.
    Saely, C. H.
    Vonbank, A.
    Woess, M.
    Jankovic, V.
    Boehnel, C.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2008, 29 : 101 - 101
  • [13] Subclinical cardiovascular disease in metabolic syndrome
    Dumitrescu, S. I.
    Tintoiu, I.
    Manole, C.
    Orosan, R.
    Vicol, M.
    Greere, V.
    Raduta, I.
    Moscaliuc, I.
    Neagoe, G.
    Voicu, V. A.
    EUROPEAN HEART JOURNAL, 2008, 29 : 101 - 102
  • [14] The Finnish diabetes risk score (FINDRISC) as a marker of coronary disease risk, metabolic syndrome, subclinical inflammation and hepatic steatosis
    Santos, R. D.
    Conceicao, R. D.
    Carvalho, J. A. M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 1004 - 1005
  • [15] Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease
    Campbell, Duncan J.
    Somaratne, Jithendra B.
    Jenkins, Alicia J.
    Prior, David L.
    Yii, Michael
    Kenny, James F.
    Newcomb, Andrew E.
    Schalkwijk, Casper G.
    Black, Mary J.
    Kelly, Darren J.
    CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [16] Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease
    Duncan J Campbell
    Jithendra B Somaratne
    Alicia J Jenkins
    David L Prior
    Michael Yii
    James F Kenny
    Andrew E Newcomb
    Casper G Schalkwijk
    Mary J Black
    Darren J Kelly
    Cardiovascular Diabetology, 10
  • [17] Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes
    Ingelsson, Erik
    Sullivan, Lisa M.
    Murabito, Joanne M.
    Fox, Caroline S.
    Benjamin, Emelia J.
    Polak, Joseph F.
    Meigs, James B.
    Keyes, Michelle J.
    O'Donnell, Christopher J.
    Wang, Thomas J.
    D'Agostino, Ralph B., Sr.
    Wolf, Philip A.
    Vasan, Ramachandran S.
    DIABETES, 2007, 56 (06) : 1718 - 1726
  • [18] Screening for the metabolic syndrome in subjects with migraine
    Streel, Sylvie
    Donneau, Anne-Francoise
    Dardenne, Nadia
    Hoge, Axelle
    Albert, Adelin
    Schoenen, Jean
    Guillaume, Michele
    CEPHALALGIA, 2017, 37 (12) : 1180 - 1188
  • [19] Coronary artery disease is a strong determinant of left ventricular stiffness in subjects with the metabolic syndrome and type 2 diabetes
    Diamant, Michaela
    De Leth, Richard
    Tushuizen, Maarten E.
    Vlasblom, Ronald
    Paulus, Walter J.
    DIABETES, 2007, 56 : A594 - A594
  • [20] ROLES OF THE METABOLIC SYNDROME AND CORONARY ATHEROSCLEROSIS IN SUBCLINICAL INFLAMMATION
    Rein, P.
    Saely, C. H.
    Beer, S.
    Vonbank, A.
    Drexel, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 32 - 32
12345